Krisztina Zsebo
Fondatore presso VST-Bio Corp.
Posizioni attive di Krisztina Zsebo
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Biovest Consulting, LLC | Presidente | 01/08/2015 | - |
| VST-Bio Corp. | Direttore/Membro del Consiglio | 01/01/2022 | - |
| Fondatore | 01/01/2020 | - | |
| Amministratore Delegato | 01/01/2020 | 01/01/2022 |
Storia della carriera di Krisztina Zsebo
Precedenti posizioni note di Krisztina Zsebo
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOCARDIA INC | Direttore/Membro del Consiglio | 22/12/2020 | 18/10/2023 |
| Independent Dir/Board Member | 22/12/2020 | 18/10/2023 | |
VasoRx, Inc.
 VasoRx, Inc. Pharmaceuticals: MajorHealth Technology VasoRx, Inc. operates as a biotechnology company. It develops solutions for atherosclerotic plaque regression. The company was founded in 2018 and is headquartered in Santa Barbara, CA. | Direttore/Membro del Consiglio | 01/04/2018 | 01/01/2022 |
| Amministratore Delegato | 01/04/2018 | 01/01/2022 | |
| Presidente | 01/04/2018 | 01/01/2022 | |
Celladon Corp.
 Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 21/05/2012 | 01/06/2015 |
| Amministratore Delegato | 30/11/2009 | 01/06/2015 | |
| Presidente | 01/01/2004 | 02/06/2014 | |
Enterprise Partners Venture Capital
 Enterprise Partners Venture Capital Investment ManagersFinance Enterprise Partners Venture Capital (Enterprise Partners) is a venture capital firm founded in 1985. The firm is headquartered in La Jolla, California. | Corporate Officer/Principal | - | 31/12/2008 |
| ALZA CORPORATION | Corporate Officer/Principal | 20/10/1998 | - |
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Corporate Officer/Principal | - | - |
Anaborex, Inc.
 Anaborex, Inc. Medical/Nursing ServicesHealth Services Anaborex, Inc. provides clinical research services for metabolic diseases. The company develops drugs for the treatment of cancer related wasting syndrome. It was founded in 2005 by Alan Saven and Jorge Nieva and is located in La Jolla, CA | Direttore/Membro del Consiglio | - | - |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Krisztina Zsebo
| Oregon State University | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
| University of Maryland | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 18 |
Posizioni
| Director/Board Member | 6 |
| Corporate Officer/Principal | 6 |
| Chief Executive Officer | 4 |
Settori
| Health Technology | 10 |
| Consumer Services | 4 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| CG ONCOLOGY, INC. | Health Technology |
| BIOCARDIA INC | Health Technology |
| Aziende private | 11 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Health Technology |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Health Technology |
Anaborex, Inc.
Anaborex, Inc. Medical/Nursing ServicesHealth Services Anaborex, Inc. provides clinical research services for metabolic diseases. The company develops drugs for the treatment of cancer related wasting syndrome. It was founded in 2005 by Alan Saven and Jorge Nieva and is located in La Jolla, CA | Health Services |
Enterprise Partners Venture Capital
Enterprise Partners Venture Capital Investment ManagersFinance Enterprise Partners Venture Capital (Enterprise Partners) is a venture capital firm founded in 1985. The firm is headquartered in La Jolla, California. | Finance |
Remedyne Corp.
 Remedyne Corp. Packaged SoftwareTechnology Services Remedyne Corp. develops software for asset management. | Technology Services |
Actavalon, Inc.
 Actavalon, Inc. Pharmaceuticals: MajorHealth Technology Actavalon, Inc. operates as a preclinical stage pharmaceutical company. It focuses on the development of a single, broad spectrum, drug with the potential to target and eradicate human cancer cells of all types such as breast, lung, pancreatic and colon cancer among others. The company was founded by Ned Israelsen and Wesley G. Hatfield and is headquartered in San Diego, CA. | Health Technology |
VasoRx, Inc.
VasoRx, Inc. Pharmaceuticals: MajorHealth Technology VasoRx, Inc. operates as a biotechnology company. It develops solutions for atherosclerotic plaque regression. The company was founded in 2018 and is headquartered in Santa Barbara, CA. | Health Technology |
| Biovest Consulting, LLC | |
| VST-Bio Corp. |
- Borsa valori
- Insiders
- Krisztina Zsebo
- Esperienza